发明名称 |
Phyllanthus-derived compounds for the prevention and/or treatment of diseases associated with a retrovirus |
摘要 |
The present invention relates to the use a Phyllanthus extract or a fraction thereof or a gallotannin or a combination of gallotannins for the preparation of a pharmaceutical composition for the prevention or treatment of retrovirus related diseases associated with a nucleosidic inhibitor-resistant retrovirus and/or a non-nucleosidic inhibitor-resistant retrovirus. Preferably, the retrovirus is a human immunodeficiency virus (HIV). In accordance with the present invention, it is further preferred that said gallotannin or combination of gallotannins is or comprises corilagin and/or geraniin and another ellagitannin. Further preferred is that said Phyllanthus is Phyllanthus amarus. |
申请公布号 |
AU2059402(A) |
申请公布日期 |
2002.04.15 |
申请号 |
AU20020020594 |
申请日期 |
2001.10.05 |
申请人 |
CMI-CENTERS FOR MEDICAL INNOVATION AG |
发明人 |
RALF WAGNER;FRANK NOTKA |
分类号 |
A61K31/366;A61K31/7024;A61K36/47;A61P31/14;A61P31/18 |
主分类号 |
A61K31/366 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|